JP Morgan Private Wealth Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,760
Closed -$336K 1936
2022
Q3
$336K Sell
19,760
-10,334
-34% -$222K ﹤0.01% 1610
2022
Q2
$646K Buy
30,094
+3,899
+15% +$108K ﹤0.01% 1349
2022
Q1
$969K Sell
26,195
-596
-2% -$23.2K ﹤0.01% 1240
2021
Q4
$1.22M Sell
26,791
-3,485
-12% -$182K ﹤0.01% 1143
2021
Q3
$1.92M Sell
30,276
-950
-3% -$72.3K ﹤0.01% 925
2021
Q2
$2.86M Buy
31,226
+16,105
+107% +$1.28M 0.01% 745
2021
Q1
$1.03M Sell
15,121
-17,546
-54% -$1.36M ﹤0.01% 1020
2020
Q4
$2.37M Buy
32,667
+27,276
+506% +$1.58M 0.01% 675
2020
Q3
$205K Buy
+5,391
New +$182K ﹤0.01% 1513

Other funds holding CDNA

JP Morgan Private Wealth Advisors's CDNA Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of CareDx (CDNA) in Q4 2022, closing a stake of 19,760 shares — an estimated $336K sold.

JP Morgan Private Wealth Advisors first reported a position in CDNA in Q3 2020 and held it in 9 quarters. The position peaked at $2.86M in Q2 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 19,760 CareDx shares in Q4 2022, an estimated $336K.
  • JP Morgan Private Wealth Advisors first reported a position in CareDx in Q3 2020 and held it in 9 quarters.
  • JP Morgan Private Wealth Advisors's CareDx position peaked at $2.86M in Q2 2021.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.